Philip K. Yachmetz, EVP, Chief Business Officer at SAVIENT PHARMACEUTICALS INC (SVNT), sold 15,000 shares at $23.47 ($355K) on 2008-01-02, disclosed to the SEC on 2008-01-04.
Open-market sale of $355k SVNT by EVP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.47 | 5,000 | $117K | 33.1% |
| 2 | $24.26 | 5,000 | $121K | 34.2% |
| 3 | $23.27 | 5,000 | $116K | 32.8% |
| Total | $23.67 avg | 15,000 | $355K | 100% |
| Filing → |
| SVNT | SELL | 2013-01-16 | $1K | — | Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | BUY | 2011-09-16 | $29K | — | Filing → |